Advertisement
Organisation › Details
Tokai Pharmaceuticals, Inc. (Nasdaq: TKAI)
Start | 2015-03-17 existent | |
Industry | cancer drug | |
Industry 2 | circulating tumor cell technology (CTC technology) | |
Person | Morrison, Jodie (Cadent Therapeutics 202012 CEO formerly Tokai Pharmaceuticals 201503 CEO) | |
Region | Cambridge, MA | |
Country | United States (USA) | |
Street | One Broadway 14th Floor | |
City | 02142 Cambridge, MA | |
Tel | +1-617-225-4305 | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | n. a. |
Record changed: 2023-07-10 |
Advertisement
More documents for Tokai Pharmaceuticals, Inc. (Nasdaq: TKAI)
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top